首页> 外文期刊>Endocrine. >Cons: endoscopic endonasal transsphenoidal pituitary surgery is not superior to microscopic transsphenoidal surgery for pituitary adenomas
【24h】

Cons: endoscopic endonasal transsphenoidal pituitary surgery is not superior to microscopic transsphenoidal surgery for pituitary adenomas

机译:缺点:内镜下的内切蛋白垂体垂体手术不优于垂体腺瘤的显微晶状体手术

获取原文
获取原文并翻译 | 示例
       

摘要

The introduction of the endoscope to transsphenoidal pituitary surgery is not new and it has been abandoned in the past. Now, after some technological advances has been proposed again as an advancement in this field. However, there is still a debate on this topic and some authors consider endoscopic surgery a form of developing surgery in an evolution step. The use of the endoscope to visualize the sella has been suggested to offer a better visualization as well as an improved range of motion compared to the operating microscope. However, the real advantage in terms of efficacy and safety is still matter of debate. The conversion to microsurgery has been reported in a significant number of cases, particularly in recurrences, where the difficulties of reoperation require more skill. There is evidence in recent studies that the endonasal and bleeding complications are significantly higher in endoscopic approaches than in microscopic ones. In particular, patient discomfort, smell, and taste impairment are higher with the endoscopic method compared with microscopic approaches. At present pure endoscopic transsphenoidal surgery is not a cost effective technology. In fact, the operative time is longer than in microscopic approaches and the number of surgeons required for the procedure is usually double compared to microscopic approaches. This paper will outline on the basis of the data available in literature the reasons why, at present, the pure endoscopic endonasal transsphenoidal surgery should not be yet considered the standard technique for transsphenoidal surgery in patients with pituitary adenomas.
机译:引入过静脉垂体手术的内窥镜并不是新的,而且它已被遗弃在过去。现在,经过一些技术进步,再次提出作为该领域的进步。但是,关于这一主题仍然存在争论,一些作者认为内窥镜手术在演变步骤中表现出一种发展手术。已经建议使用内窥镜来可视化SELLA,以提供更好的可视化以及与操作显微镜相比的改进的运动范围。然而,在效力和安全方面的实际优势仍然是辩论的重要性。在大量病例中报道了对显微外科的转化,特别是在复发中,重新进食的困难需要更多技能。最近有证据表明内窥镜和出血并发症的内窥镜方法明显高于微观方法。特别是,与微观方法相比,患者的不适,气味,气味和味道损伤更高。目前纯内镜晶状体手术不是一种成本效益的技术。实际上,与微观方法相比,操作时间比在微观方法中长于微观方法,并且程序所需的外科医生的数量是双重的。本文将在文献中提供的数据概述原因,目前,纯内镜内蒙类晶状体手术尚不应算是垂体腺瘤患者经胸腔手术的标准技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号